|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_ocn975222663 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
170311s2017 mou ob 001 0 eng d |
| 010 |
|
|
|a 2016960462
|
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d CASUM
|d OCLCO
|d OCLCQ
|d OCLCA
|d WYU
|d OCLCO
|d UHL
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCA
|d OCLCQ
|d VT2
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1066448832
|a 1235829228
|
| 020 |
|
|
|a 9780128043219
|
| 020 |
|
|
|a 0128043210
|
| 020 |
|
|
|z 9780128042748
|
| 020 |
|
|
|z 0128042745
|
| 029 |
1 |
|
|a AU@
|b 000068485618
|
| 029 |
1 |
|
|a AU@
|b 000068464294
|
| 035 |
|
|
|a (OCoLC)975222663
|z (OCoLC)1066448832
|z (OCoLC)1235829228
|
| 050 |
|
4 |
|a RC846.9
|b .L58 2017
|
| 060 |
|
4 |
|a 2017 E-643
|
| 060 |
|
4 |
|a WI 700
|
| 082 |
0 |
4 |
|a 616.3607
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Muriel, Pablo.
|
| 245 |
1 |
0 |
|a Liver Pathophysiology :
|b Therapies and Antioxidants.
|
| 260 |
|
|
|a Saint Louis :
|b Elsevier Science,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (917 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; Liver Pathophysiology; Liver Pathophysiology: Therapies and Antioxidants; Copyright; Dedication; Hepatic Cirrhosis; CIRROSIS HEPATICA; Contents; List of Contributors; Foreword; Acknowledgments; I -- Introduction; 1 -- The Liver: General Aspects and Epidemiology; ABBREVIATED HISTORY OF HEPATOLOGY; LIVER ANATOMY AND PHYSIOLOGY; Liver Anatomy; Bile Ducts; Blood Vessels; LIVER CELLS; The Hepatocyte and the Regenerative Capacity of the Liver; Pit Cells Exert Antitumor Functions; LSECs Play a Prominent Role in Homeostasis; KCs Are the First Line of Defense of the Organism.
|
| 505 |
8 |
|
|a HSCs Are the Main Executors in FibrogenesisLIVER ZONATION ALLOWS FUNCTIONAL PLASTICITY; Regulation of Zonation of the Liver; Metabolic Zonal Functions; GLOBAL LIVER EPIDEMIOLOGY; Hepatocellular Carcinoma Epidemiology; Risk Factors That May Lead to HCC; Hepatitis B Virus; HCV Is a Major Risk Factor for HCC Development; Ethanol Abuse Is Associated to HCC; Aflatoxin Is a Potent Carcinogen; Nonalcoholic Steatohepatitis Can Progress to Cirrhosis and HCC; Diabetes Mellitus Type 2 Is an Independent Risk Factor for HCC; Tobacco Smoking Increases the Risk of Mortality in Patients With HCC.
|
| 505 |
8 |
|
|a Alcohol Liver Disease EpidemiologyRisk Factors for ALD; Epidemiology of NAFLD and NASH; Risk Factors for NAFLD and NASH; Chronic HCV Epidemiology; Risk Factors for Chronic HCV; Epidemiology of Primary Biliary Cirrhosis; Risk Factors for PBC; Epidemiology of Drug-Induced Liver Injury; Intrinsic DILI; Idiosyncratic DILI; Epidemiology of Liver Abscess; Risk Factors for LA; Concluding Remarks; ACKNOWLEDGMENT; REFERENCES; 2 -- Structure and Ultrastructure of the Normal and Diseased Liver; INTRODUCTION; NORMAL LIVER CELL TYPES; Parenchymal Cells; Hepatocytes; Nonparenchymal Cells; Endothelial Cells.
|
| 505 |
8 |
|
|a Kupffer Cells (Macrophages)Stellate Cells; Cholangiocytes; Pit Cells; PATHOLOGY OF THE DISEASED LIVER; Acute Viral Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Steatosis and Steatohepatitis; Steatosis; Steatohepatitis, Nonalcoholic and Alcoholic; Chronic Hepatitis; Chronic Hepatitis B; Chronic Hepatitis C; Autoimmune Hepatitis; Cirrhosis; Liver Neoplasms; Liver Cell Adenoma; Focal Nodular Hyperplasia; Nodular Regenerative Hyperplasia; Hemangioma; Malignant Lesions; Precursors of Hepatocellular Carcinoma; Hepatocellular Carcinoma; Fibrolamellar Carcinoma.
|
| 505 |
8 |
|
|a Bile Duct Carcinoma (Cholangiocarcinoma)CONCLUDING REMARKS; ACKNOWLEDGMENTS; REFERENCES; FURTHER READING; II -- Liver Pathophysiology; 3 -- Hepatic Apoptosis and Necrosis: Mechanisms and Clinical Relevance; INTRODUCTION OF HEPATIC INJURY; APOPTOSIS AND NECROSIS; Apoptosis; Necrosis; MECHANISM OF LIVER INJURY AND DISEASE RELEVANCE; Chronic Viral Hepatitis; The Cytopathic Effects Mediated by Immune Response in Viral Hepatitis; The Direct Cytopathic Effects of Viruses; Alcohol Liver Disease; Nonalcoholic Fatty Liver Disease; Drug-Induced Liver Injury; Hepatocellular Carcinoma.
|
| 500 |
|
|
|a THERAPEUTIC STRATEGIES FOR LIVER INJURY.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Liver
|x Pathophysiology.
|
| 650 |
1 |
2 |
|a Liver Diseases
|x physiopathology
|
| 650 |
1 |
2 |
|a Liver Diseases
|x therapy
|
| 650 |
2 |
2 |
|a Antioxidants
|x therapeutic use
|
| 650 |
2 |
2 |
|a Liver
|x physiopathology
|
| 650 |
|
6 |
|a Foie
|x Physiopathologie.
|
| 650 |
|
7 |
|a Liver
|x Pathophysiology
|2 fast
|
| 655 |
|
4 |
|a Fulltext.
|
| 655 |
|
4 |
|a Internet Resources.
|
| 655 |
|
4 |
|a Portraits.
|
| 776 |
0 |
8 |
|i Print version:
|a Muriel, Pablo.
|t Liver Pathophysiology : Therapies and Antioxidants.
|d Saint Louis : Elsevier Science, ©2017
|z 9780128042748
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4816314
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4816314
|
| 994 |
|
|
|a 92
|b IZTAP
|
